Top Industry News

The latest from small and Emerging Pharma companies featuring Encoded Therapeutics, Solstice Oncology, TwoStep Therapeutics, Superluminal, and Medicus Pharma.  For news on the large and mid-sized bio/pharmaceutical companies, see Global…

Eli Lilly and Company has agreed to acquire Merida Biosciences, a Cambridge, Massachusetts-based clinical-stage bio/pharmaceutical company advancing precision therapeutics for autoimmune and allergic diseases, for $2.875 billion.   Merida is developing…

Bristol Myers Squibb (BMS), through its subsidiary RayzeBio, has announced plans to build a new $173-million, 225,000-square-foot radiopharmaceutical manufacturing facility in Whitestown, Indiana. The new facility, which is expected to…

Novartis and Alteogen, a Daejon, South Korea-based bio/pharmaceutical company developing antibody drug conjugates, biobetters, and biosimilars, have entered into an option and license agreement for the development and commercialization of…

The latest from CDMOs, CMOs, and suppliers featuring Evonik, Hovione, Samsung Biologics, Catalent, Celonic Group, Lonza, Artis BioSolutions and Barentz.   Biologics Manufacturing * Artis BioSolutions Opens Genetic Center of ExcellenceFormulation Development/Drug…

A roundup of news from the large and mid-sized bio/pharmaceutical companies featuring Roche, AstraZeneca, GSK, and SK Biopharmaceuticals. Highlights below.   For the latest news roundup on small and Emerging Pharma…

The latest from small and Emerging Pharma companies featuring Haisco Pharmaceutical, Sentivera and SpyGlass Pharma.  For news on the large and mid-sized bio/pharmaceutical companies, see Global Briefs.  * Haisco, Sentivera…

Roche’s Genentech has completed the structural framework of its new $2-billion biomanufacturing facility in Holly Springs, North Carolina. Additionally, the company has announced plans to invest approximately $750 million in…

President Donald Trump has nominated Dr. Heidi Overton, M.D., currently Deputy Director of the White House Domestic Policy Council, to serve as the next Commissioner of the US Food and…

BioMarin Pharmaceutical, a San Rafael, California-based bio/pharmaceutical company focused on rare diseases, has agreed to acquire Alesta Therapeutics, a Leiden, the Netherlands-based clinical-stage bio/pharmaceutical company developing small-molecule drugs for rare…